Home/Filings/4/0001209191-21-071405
4//SEC Filing

Halkias Theodore 4

Accession 0001209191-21-071405

CIK 0001831097other

Filed

Dec 27, 7:00 PM ET

Accepted

Dec 28, 5:50 PM ET

Size

15.3 KB

Accession

0001209191-21-071405

Insider Transaction Report

Form 4
Period: 2021-12-23
Halkias Theodore
Chief Business Officer
Transactions
  • Exercise/Conversion

    Options (Rights to Buy)

    2021-12-275,5831,714,722 total
    Exercise: $1.00Exp: 2027-04-27Common Stock (5,583 underlying)
  • Exercise/Conversion

    Common Stock

    2021-12-27$1.00/sh+5,583$5,58311,017 total
  • Sale

    Common Stock

    2021-12-27$27.53/sh5,583$153,7005,434 total
  • Exercise/Conversion

    Common Stock

    2021-12-23$1.00/sh+21,142$21,14226,576 total
  • Sale

    Common Stock

    2021-12-23$27.52/sh21,142$581,8285,434 total
  • Exercise/Conversion

    Options (Rights to Buy)

    2021-12-2321,1421,720,305 total
    Exercise: $1.00Exp: 2027-04-27Common Stock (21,142 underlying)
Footnotes (5)
  • [F1]Includes restricted stock units.
  • [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, which was adopted prior to September 7, 2021.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $27.50 to $27.62, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  • [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $27.50 to $27.58, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  • [F5]These options were granted on April 27, 2017 and vested in four equal installments on May 15th of each of 2018, 2019, 2020, and 2021.

Issuer

agilon health, inc.

CIK 0001831097

Entity typeother

Related Parties

1
  • filerCIK 0001855972

Filing Metadata

Form type
4
Filed
Dec 27, 7:00 PM ET
Accepted
Dec 28, 5:50 PM ET
Size
15.3 KB